The Blue Venture Fund invests in healthcare technology, services, and clinical sciences companies to drive better health outcomes and deliver superior value to patients. Their strategy involves a unique partnership among Blue Cross Blue Shield companies, focusing on long-term strategic collaborations to foster innovation and commercialize solutions within the healthcare ecosystem.
Portfolio
8
Fund Size
—
Top Stage
Series A
Last 12 Mo
1
Team
ES
Emir Sandhu
Managing Director
Stage Distribution
Portfolio
8 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Daymark Health | Series A | $20M | Sep 2025 |
| Upward Health | Series C | — | Jan 2025 |
| Tuesday Health | Series C | $60M | May 2024 |
| Sempre Health | Series B | $20M | Sep 2023 |
| Limber Health | Series A | $11M | Oct 2022 |
| Bluestone Physician Services | Unknown | — | Aug 2021 |
| Sempre Health | Series B | $15M | Jun 2021 |
| Insightin Health | Series A | $12M | Feb 2021 |
Top Co-Investors
Industry Ventures1 shared
Valtruis1 shared
Mass General Brigham Ventures1 shared
Trinity Capital Inc.1 shared
Comerica Bank1 shared
Heritage Group1 shared
Blue Heron Capital1 shared
Health Catalyst Capital1 shared
Revolution's Rise of the Rest Fund1 shared
Healthier Capital1 shared
Yosemite1 shared
Maverick Ventures1 shared
Oncology Ventures1 shared
Last updated: 1 March 2026